Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.070
-0.250 (-10.78%)
At close: Nov 4, 2024, 4:00 PM
2.100
+0.030 (1.45%)
After-hours: Nov 4, 2024, 5:11 PM EST
Gain Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 53 | 49 | 37 | 65 | - | - | |
| Market Cap Growth | -41.67% | 32.75% | -42.34% | - | - | - | |
| Enterprise Value | 37 | 38 | 13 | 25 | - | - | |
| Last Close Price | 2.07 | 3.27 | 3.13 | 5.43 | - | - | |
| PE Ratio | - | -1.91 | -2.11 | -3.97 | - | - | |
| PS Ratio | - | 894.85 | 280.42 | 481.65 | - | - | |
| PB Ratio | 4.42 | 3.93 | 1.97 | 1.85 | - | - | |
| P/FCF Ratio | -1.70 | -2.62 | -2.51 | -5.18 | - | - | |
| P/OCF Ratio | -1.70 | -2.62 | -2.53 | -5.22 | - | - | |
| EV/Sales Ratio | - | 691.99 | 96.63 | 186.53 | - | - | |
| EV/EBITDA Ratio | -0.94 | -1.72 | -0.72 | -1.81 | - | - | |
| EV/EBIT Ratio | -0.94 | -1.72 | -0.72 | -1.81 | - | - | |
| EV/FCF Ratio | -1.08 | -2.02 | -0.87 | -2.00 | - | - | |
| Debt / Equity Ratio | 0.07 | 0.08 | 0.07 | 0.05 | 0.20 | -0.45 | |
| Debt / FCF Ratio | -0.04 | -0.05 | -0.09 | -0.13 | -0.39 | -0.11 | |
| Asset Turnover | - | 0.00 | 0.00 | 0.01 | - | - | |
| Quick Ratio | 2.64 | 3.44 | 4.93 | 14.53 | 3.57 | 0.40 | |
| Current Ratio | 2.84 | 3.59 | 5.11 | 14.78 | 4.25 | 0.49 | |
| Return on Equity (ROE) | -188.83% | -141.57% | -65.52% | -67.73% | -124.39% | - | |
| Return on Assets (ROA) | -72.96% | -65.14% | -35.24% | -35.60% | -42.37% | -178.35% | |
| Return on Capital (ROIC) | -110.06% | -82.41% | -39.30% | -39.41% | -60.29% | -2487.10% | |
| Earnings Yield | -40.86% | -45.10% | -47.29% | -21.53% | - | - | |
| FCF Yield | -35.93% | -38.24% | -39.82% | -19.32% | - | - | |
| Buyback Yield / Dilution | -35.04% | -9.49% | -16.90% | -279.11% | -19.17% | - | |
| Total Shareholder Return | -35.04% | -9.49% | -16.90% | -279.11% | -19.17% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.